Immune landscape and biomarkers for immuno-oncology in colorectal cancers
Recent advances in immuno-oncology have increased understanding of the tumor immune microenvironment (TIME), and clinical trials for immune checkpoint inhibitor treatment have shown remission and/or durable response in certain proportions of patients stratified by predictive biomarkers. The TIME in...
Main Authors: | Jeong Mo Bae, Seung-Yeon Yoo, Jung Ho Kim, Gyeong Hoon Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology
2020-09-01
|
Series: | Journal of Pathology and Translational Medicine |
Subjects: | |
Online Access: | http://www.jpatholtm.org/upload/pdf/jptm-2020-05-15.pdf |
Similar Items
-
Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
by: Jung Ho Kim, et al.
Published: (2015-03-01) -
Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
by: Núria Mulet-Margalef, et al.
Published: (2023-02-01) -
Immunotherapy, Inflammation and Colorectal Cancer
by: Charles Robert Lichtenstern, et al.
Published: (2020-03-01) -
The Clinical Significance of Microsatellite Instability in Patients with Right-sided Colorectal Cancer
by: Seo Ae Han, et al.
Published: (2019-03-01) -
Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry
by: Jiyoon Jung, et al.
Published: (2017-03-01)